Flavonoids protect LDL from oxidation and attenuate atherosclerosis

Current Opinion in Lipidology

Volumn 12, Issue 1, 2001, Pages 41-48

  Fuhrman, Bianca ^a   Aviram, Michael ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; FLAVONOID; GLUTATHIONE; LOW DENSITY LIPOPROTEIN; METAL ION; NICOTINAMIDE ADENINE DINUCLEOTIDE; OXYGENASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; SCAVENGER;

ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CHELATION; DIETARY INTAKE; ENDOTHELIUM CELL; ENZYME INHIBITION; FOAM CELL; LIPID PEROXIDATION; OXIDATIVE STRESS; PLANT; PRIORITY JOURNAL; REVIEW; VASCULAR ENDOTHELIUM;

ANTIOXIDANTS; ARTERIOSCLEROSIS; DIET; FLAVONOIDS; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MACROPHAGES; OXIDATION-REDUCTION; PLANTS, EDIBLE;

EID: 0035140416     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200102000-00008     Document Type: Review

References (66)

1. Low density lipoprotein oxidation and its pathobiological significance
2. The role of oxidized lipoproteins in atherosclerosis
3. Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases
4. Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis and the antiatherogenicity of antioxidants
5. Oxidized low-density lipoprotein, a two-faced janus in coronary artery disease?
6. Oxidized low density lipoprotein: Atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase
7. Antioxidants in restenosis and atherosclerosis
8. Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and antioxidants in arterial cells and in blood lipoproteins: A need for a dual approach
9. Lesioned low density lipoprotein in atherosclerotic apolipoprotein E-deficient transgenic mice and in humans is oxidized and aggregated
10. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids
11. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture
12. Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor
13. Macrophage mediated oxidation of extracellular low density lipoprotein requires an initial binding of the lipoprotein to its receptor
14. Activation of NADPH oxidase is required for macrophage-mediated oxidation of low density lipoprotein
15. Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions
16. Microsomal cytochromes P450 catalyze the oxidation of low density lipoprotein
17. Mechanism of oxidative damage of low density lipoprotein in human atherosclerosis
18. Pathways for oxidation of low density lipoprotein by myeloperoxidase: Tyrosyl radical, reactive aldehydes, hypochlorous acid and molecular chlorine
19. Iron induces lipid peroxidation in cultured macrophages, increases their ability to oxidatively modify LDL and affect their secretory properties
20. Increased uptake of low density lipoprotein (LDL) by oxidized macrophages is the result of enhanced LDL receptor activity and of progressive LDL oxidation
21. Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: Selective action of human paraoxonase allozymes Q and R
22. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase
23. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study
24. The relative antioxidant activities of plant-derived polyphenolic flavonoids
25. Structure-antioxidant activity relationships of flavonoids and phenolic acids
26. Structural aspects of antioxidants activity of flavonoids
27. Dietary consumption of ginger extract attenuates development of atherosclerosis in the atherosclerotic apolipoprotein E deficient mice: Hypocholesterolemic and antioxidative effects
28. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance
29. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL and platelet aggregation: Studies in humans and in the atherosclerotic apolipoprotein E deficient mice
30. Dietary olive oil reduces low-density lipoprotein uptake by macrophages and decreases the susceptibility of the lipoprotein to undergo lipid peroxidation
31. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease
32. Effect of tea flavonoid supplementation on the susceptibility of low density lipoprotein to oxidative modification
33. Tea and health: The underlying mechanisms
34. In vivo antioxidant effect of green and black tea in man
35. Drinking green tea leads to a rapid increase in plasma antioxidant potential
36. Consumption of green or black tea does not increase resistance of low density lipoprotein to oxidation in humans
37. Black tea consumption does not protect low density lipoprotein from oxidative modification
38. No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers
39. Plant-derived phenolic antioxidants
40. Consumption of red wine with meals reduces the susceptibility of human plasma and LDL to undergo lipid peroxidation
41. Consumption of red wine polyphenols reduces the susceptibility of low density lipoproteins to oxidation in vivo
42. Ingestion of red wine significantly increases plasma phenolic acid concentrations but does not acutely affect ex vivo lipoprotein oxidizability
43. Licorice extract and its major polyphenol glabridin protect low-density lipoprotein against lipid peroxidation: In vitro and ex vivo studies in humans and in atherosclerotic apolipoprotein E-deficient mice
44. The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation
45. Reduced progression of atherosclerosis in the apolipoprotein E deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation
46. Incorporation of esterified soybean isoflavones with antioxidant activity into low density lipoprotein
47. (+)-Catechin prevents human plasma oxidation
48. Proanthocyanidin-rich extract from grape seeds attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits
49. Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages
50. Flavonoids in food and natural antioxidants in wine
51. Structural aspects of the inhibitory effect of glabridin on LDL oxidation
52. 2+ ions: Implications for their antioxidant properties
53. Inhibition of human low density lipoprotein oxidation by caffeic acid and other hydroxycinnamic acid derivatives
54. Lycopene synergistically inhibits LDL oxidation in combination with vitamin E, glabridin, rosmarinic acid, carnosic acid, or garlic
55. Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids
56. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants
57. LDL oxidation by arterial wall macrophages depends on the antioxidative status in the lipoprotein and in the cells: Role of prooxidants vs. antioxidants
58. Polyphenolic flavonoids inhibit macrophage-mediated oxidation of LDL and attenuate atherogenesis
59. Red wine inhibits the cell-mediated oxidation of LDL and HDL
60. Macrophage enrichment with the isoflavan glabridin inhibits NADPH oxidase-induced cell mediated oxidation of low density lipoprotein
61. Inhibitory effect of tea flavonoids on the ability of cells to oxidize low density lipoprotein
62. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production
63. Inhibition of mammalian 15-lipoxygenase-dependent lipid peroxidation in low-density lipoprotein by quercetin and quercetin monoglucosides
64. Inhibition of xanthine oxidase by catechins from tea (Camelia sinensis)
65. Increased plasma lipoprotein lipid peroxidation in apo E-deficient mice
66. Effect of red wine consumption on low density lipoprotein oxidation and atherosclerosis in aorta and coronary artery in Watanabe heritable hyperlipidemic rabbits